Strategic and Scientific Advancements in Pharmaceutical Formulation and Delivery
Guildford, UK, and Burlington, Mass., January 13, 2011 – IDBS, the leading worldwide provider of data management and analytics solutions to R&D and healthcare organizations, today announced it will present a session entitled ‘Improving Formulation Delivery Through Information and Context Management’ at the World Trade Group (WTG’s) 2011 World Drug Delivery and Formulations Conference January 17-18 in Berlin. Scientific and business leaders from a variety of pharmaceutical disciplines will attend this year’s conference to discuss cutting edge delivery and formulation techniques, share best practices and strategies, and network with peers.
Formulators and formulation development are critical in the drug development process. Formulators need to assimilate data from a wide variety of sources across many functional areas and disciplines, but this data is often locked inside paper notebooks and static reports, making it difficult and time consuming to locate and retrieve information, share it with colleagues and perform meaningful analysis.
Furthermore, inefficient communication between business units makes data and information difficult to trace, slowing down the formulation development process. The increased application of Quality by Design (QbD) in the pharmaceutical industry requires a more systematic approach to achieving quality and characterizing acceptable variations in formulation development processes. This brings a different approach to regulatory submissions and manufacturing flexibility, and requires a comprehensive data management strategy across all stages of the development process.
In their session, IDBS presenters Dr. Stuart Ward and Mr. David McManus will discuss how the combination of good data management and powerful search capabilities provides enhanced visibility of all data pertaining to formulations and results in better decision-making and faster time-to-market.
The 2011 conference will be held January 17-18 at the Maritim ProArte Hotel in Berlin, Germany. Dr. Ward and Mr. McManus will present on January 17, at 12:45. For more information on the conference or to register, visit www.ddfevent.com.
IDBS is a unique, global supplier of innovative data management and first-in-class analytics solutions which increase efficiency reduce costs and improve the productivity of healthcare R&D organizations. Multinational pharmaceutical companies, major public-private healthcare partnerships, global leaders in academic study and high tech companies employ IDBS as a strategic supplier of scientific informatics and business process improvement solutions. IDBS is clearly differentiated by its unique combination of deep domain knowledge across the entire R&D sector: from the examination of the human genome at the scientist’s bench, through the clinic, to translational medicine initiatives and pay-for-performance healthcare monitoring. IDBS solutions support the protection of intellectual property (IP) and the requirements for data quality and security demanded under Good Laboratory Practice (GLP), Good Manufacturing Practice (GMP) and HL7 (Health Level) standards.
Founded in 1989 and headquartered in Guildford, UK, IDBS has worldwide consulting and support presence, with offices in California, New Jersey and Massachusetts, as well as in the EU, Australia and China. IDBS is a 2010 Profit Track 100 company.